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The use of gene trap vectors in embryonic stem (ES) cells and
transgenic mice has proved to be a powerful method for identifying
new genes involved in mammalian development (1—4). Generally,
they have a lacZ marker gene downstream of a splice acceptor site
and rely on integration into introns for their expression. Not only
can insertion of these vectors cause disruption of the gene into
which they integrate, but it is also possible to visualize the
transcription pattern of the disrupted gene itself, by staining with
X-gal for expression of P-galactosidase from the lacZ gene. More
sophisticated gene trap vectors have now been developed carrying
a /acZ-neomycin fusion gene, $geo, which produces a chimaeric
fusion protein with both P-galactosidase and neomycin phospho-
transferase activities, conferring the added advantage of selection
with G418 for insertion within expressed genes (3). Such vectors
can also be used for cell marking experiments by integrating within
constitutively active genes. Recently $geo gene traps have been
successfully used to mark ES cells for in situ localization of then-
derivatives in chimaeric mice, providing a useful tool for mosaic
analysis in vivo (5).
The usefulness of figeo gene trap vectors for cell marking is
however limited to cell lines that do not already carry a neomycin
phosphotransferase (neo) gene and are thus not resistant to G418.
As neo is widely used as a selectable marker for mammalian cells,
this excludes the majority of cells carrying expression constructs,
such as ES cell lines that have undergone gene targeting events.
We have therefore created a novel gene fusion between the lacZ
and hygromycin B phosphotransferase (hyg) (6) genes, named
$gyg, and have used it to construct a gene trap vector which
carries this gene downstream of the splice acceptor site. Here we
show that the fusion protein produced by this vector has both
P-galactosidase and hygromycin phosphotransferase activities.
Moreover, we have successfully introduced this vector into a
G418 resistant ES cell line, SR2-3 (7), and by selecting for
hygromycin expression, have isolated marked clones that consti-
tutively express P-galactosidase in all cells both before and after
differentiation in vitro.
The gene trap vector we have constructed, pPgyg, is based on
pSAPgeo, which carries a $geo fusion gene downstream of the
splice acceptor site from adenovirus major late transcript (3).
Essentially, the neo gene and poly-A site from pSAPgeo has been
replaced with a hyg gene and phosphoglycerate kinase (PGK)
poly-A site from pKJ23 (M. McBurney, University of Ottawa),
such that the hyg gene is in frame with the lacZ gene to generate




Figure 1. A map of the /acZ-hygromycin gene trap vector, ppgyg, showing the
hyg gene and PGK poly-A site (grey box) fused in frame downstream of the
lacZ gene (black box). The splice acceptor site from adenovirus major late
transcript (white box) lies upstream of the lacZ gene. The vector was
constructed by digesting pKJ23 (McBumey, University of Ottawa) with BamHI
and //mdlll to generate a 1.5 kb fragment containing the hyg gene and PGK
poly-A site. This was ligated between the BamHI and //mdm sites of pUC18
to generate pUChyg. A 3.8 kb Sma\ fragment from pS Afjgeo (3) containing the
splice acceptor site and lacZ gene was then inserted into the Smal site in
pUChyg at the 5' end of the hyg gene. The nucleotide sequence of the fusion
junction between the lacZ and hyg genes is as follows: 5'-TGT cag ggg ate ccc
egg gga tec gec ace atg get AAA-3'. The codons in upper case letters are the
codons encoding amino acid 1021 in |J-galactosidase and amino acid 2 in
hygromycin phosphotransferase.
the legend to Figure 1. Sequencing across the junction of the
fusion site between the lacZ and hyg genes confirmed that they
were indeed in frame. To determine whether figyg was functional
in mammalian cells, 30 |ig of ppgyg was linearized by digesting
with Kpnl, and electroporated into 107 SR2-3 ES cells. After 14
days selection with 0.3 mg/ml hygromycin B (Sigma), 22 resistant
colonies were obtained, demonstrating that the hygromycin fusion
protein retains biological activity. Whilst hygromycin has been
reported to be active as an N-terminal fusion protein with
thymidine kinase (8), this is, to our knowledge, the first
demonstration of its activity as a C-terminal fusion with P-galac-
tosidase. Of the 22 hygromycin resistant clones, 10 (45%) stained
strongly with X-gal; of these, seven gave staining in >80% of cells
and two in 100% of cells. In both of these clones, named S3 and
S21, every cell was strongly positive after staining for 4 h, as
shown in Figure 2A for the S3 clone.
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Figure 2. Expression of (3-galactosidase in the S3 ES cell clone. (A) All the stem cells in the culture are strongly positive for expression, after staining with X-gal for
4 h. (B and C) Maintenance of P-galactosidase expression in all cells after differentiation in vitro, 2 days (B) and 6 days (C) after plating the embryoid bodies.
Magnification is x 125.
To determine whether expression of the figyg gene was main-
tained on cell differentiation, embryoid bodies were derived from the
S3 clone, as described (9). After culturing for 10 days in
bacteriological dishes, cystic embryoid bodies were obtained.
Several days after these were replated onto gelatinized tissue culture
plates, a wide variety of differentiated cell types were observed in the
cultures, including endoderm, neurones and cardiac muscle. On
staining with X-gal, all cells were positive for p-galactosidase
expression (Fig. 2B and C). This result demonstrates that the
p(3gyg gene trap vector can be used to mark ES cells and that
constitutive expression of the P-galactosidase-hygromycin
fusion protein is maintained on their differentiation.
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